Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01864564 · ClinicalTrials.gov registry record · NA
Early Gestational Diabetes Screening in the Gravid Obese Woman
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 962
- Enrollment target
NCT01864564 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 962 participants.
The verdict
NCT01864564, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 962 participants
- Enrollment target
Study Summary
Specific Aim 1: To test the hypothesis that early GDM screening between 14-18 weeks in obese women (body mass index ≥30.0) will result in improved perinatal outcomes. Specific Aim 2: To test the hypothesis that a lower diagnostic threshold for GDM at 14-18 weeks will result in improved detection of GDM and reduce the need for third-trimester testing. Specific Aim 3: To test the hypothesis that 1,5-anhydroglucitol, a sensitive marker of hyperglycemia, can be used as a simple and sensitive serum test for GDM in the obese population.
Interventions
- OTHER Early Screen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 962 participants |
| Start Date | 2013-06-18 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01864564
The ClinicalTrials.gov registry entry for NCT01864564 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 962 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Early Screen is the first listed.
NCT01864564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01864564 about?
NCT01864564 is a clinical study titled "Early Gestational Diabetes Screening in the Gravid Obese Woman". Specific Aim 1: To test the hypothesis that early GDM screening between 14-18 weeks in obese women (body mass index ≥30.0) will result in improved perinatal outcomes. Specific Aim 2: To test the hypothesis that a lower diagnostic threshold for GDM at 14-18 weeks will result in improved detection of...
What is the current status of trial NCT01864564?
This trial is currently completed. It is a NA study. The enrollment target is 962 participants. The study started on 2013-06-18. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT01864564?
The interventions under investigation include: Early Screen (OTHER).
Who is sponsoring clinical trial NCT01864564?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.